Identification of Mutator-Derived lncRNA Signatures of Genomic Instability for Promoting the Clinical Outcome in Hepatocellular Carcinoma

Figure 10

The AUC value of the time-dependent ROC curve suggested that the predicted outcome of GILncSig was better than that of TP53 mutation status. (a–c) The time-dependent ROC of GILncSig and TP53 mutation status in 1 year, 3 years, and 5 years. All AUC values of GILncSig were superior to TP53 mutation status.

(a)

(b)

(c)